Weighted gene co-expression network analysis identifies dysregulated B-cell receptor signaling pathway and novel genes in pulmonary arterial hypertension

Background Pulmonary arterial hypertension (PAH) is a devastating cardio-pulmonary vascular disease in which chronic elevated pulmonary arterial pressure and pulmonary vascular remodeling lead to right ventricular failure and premature death. However, the exact molecular mechanism causing PAH remains unclear. Methods RNA sequencing was used to analyze the transcriptional profiling of controls and rats treated with monocrotaline (MCT) for 1, 2, 3, and 4 weeks. Weighted gene co-expression network analysis (WGCNA) was employed to identify the key modules associated with the severity of PAH. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed to explore the potential biological processes and pathways of key modules. Real-time PCR and western blot analysis were used to validate the gene expression. The hub genes were validated by an independent dataset obtained from the Gene Expression Omnibus database. Results A total of 26 gene modules were identified by WGCNA. Of these modules, two modules showed the highest correlation with the severity of PAH and were recognized as the key modules. GO analysis of key modules showed the dysregulated inflammation and immunity, particularly B-cell-mediated humoral immunity in MCT-induced PAH. KEGG pathway analysis showed the significant enrichment of the B-cell receptor signaling pathway in the key modules. Pathview analysis revealed the dysregulation of the B-cell receptor signaling pathway in detail. Moreover, a series of humoral immune response-associated genes, such as BTK, BAFFR, and TNFSF4, were found to be differentially expressed in PAH. Additionally, five genes, including BANK1, FOXF1, TLE1, CLEC4A1, and CLEC4A3, were identified and validated as the hub genes. Conclusion This study identified the dysregulated B-cell receptor signaling pathway, as well as novel genes associated with humoral immune response in MCT-induced PAH, thereby providing a novel insight into the molecular mechanisms underlying inflammation and immunity and therapeutic targets for PAH.

[1]  Haomin Cai,et al.  Immune infiltration landscape and immune-marker molecular typing of pulmonary fibrosis with pulmonary hypertension , 2021, BMC Pulmonary Medicine.

[2]  G. Lian,et al.  Zinc-mediated activation of CREB pathway in proliferation of pulmonary artery smooth muscle cells in pulmonary hypertension , 2021, Cell communication and signaling : CCS.

[3]  Jing Wang,et al.  Autoimmunity in Pulmonary Arterial Hypertension: Evidence for Local Immunoglobulin Production , 2021, Frontiers in Cardiovascular Medicine.

[4]  Justyna A. Karolak,et al.  Perturbation of semaphorin and VEGF signaling in ACDMPV lungs due to FOXF1 deficiency , 2021, Respiratory Research.

[5]  M. Slevin,et al.  Pulmonary arterial hypertension (PAH) from autopsy study: T-cells, B-cells and mastocytes detection as morphological evidence of immunologically mediated pathogenesis. , 2021, Pathology, research and practice.

[6]  M. Kool,et al.  Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension , 2021, Thorax.

[7]  M. Morell,et al.  The Role of BANK1 in B Cell Signaling and Disease , 2021, Cells.

[8]  Qingchen Yuan,et al.  ECM2 and GLT8D2 in human pulmonary artery hypertension: fruits from weighted gene co-expression network analysis , 2021, Journal of thoracic disease.

[9]  D. Chaussabel,et al.  Connection of BANK1, Tolerance, Regulatory B cells, and Apoptosis: Perspectives of a Reductionist Investigation , 2021, Frontiers in Immunology.

[10]  G. Lima,et al.  BLK and BANK1 variants and interactions are associated with susceptibility for primary Sjögren's syndrome and with some clinical features. , 2021, Cellular immunology.

[11]  A. Sweatt,et al.  Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Randomized, Placebo-controlled Trial. , 2021, American journal of respiratory and critical care medicine.

[12]  Ji-Yang Wang,et al.  Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis , 2021, International journal of molecular sciences.

[13]  Shanqun Li,et al.  Essential Genes and MiRNA–mRNA Network Contributing to the Pathogenesis of Idiopathic Pulmonary Arterial Hypertension , 2020, Frontiers in Cardiovascular Medicine.

[14]  Liang-di Xie,et al.  Transcriptomic analysis identifies Toll‐like and Nod‐like pathways and necroptosis in pulmonary arterial hypertension , 2020, Journal of cellular and molecular medicine.

[15]  Ji-Na Zheng,et al.  Identification and Validation of Key Genes Associated With Systemic Sclerosis-Related Pulmonary Hypertension , 2020, Frontiers in Genetics.

[16]  Liang-di Xie,et al.  RNA sequencing analysis of monocrotaline-induced PAH reveals dysregulated chemokine and neuroactive ligand receptor pathways , 2020, Aging.

[17]  Jun Zhou,et al.  Identification of immune cells and mRNA associated with prognosis of gastric cancer , 2020, BMC Cancer.

[18]  Zhongjun Wu,et al.  Tle1 attenuates hepatic ischemia/reperfusion injury by suppressing NOD2/NF-κB signaling , 2020, Bioscience, biotechnology, and biochemistry.

[19]  A. Campos-Parra,et al.  Association of BLK and BANK1 Polymorphisms and Interactions With Rheumatoid Arthritis in a Latin-American Population , 2020, Frontiers in Genetics.

[20]  Hans C. Bernstein,et al.  Systems biology: current status and challenges , 2020, Cellular and Molecular Life Sciences.

[21]  Jun Liu,et al.  B Cell Development and Maturation. , 2020, Advances in experimental medicine and biology.

[22]  P. Stankiewicz,et al.  The S52F FOXF1 Mutation Inhibits STAT3 Signaling and Causes Alveolar Capillary Dysplasia. , 2019, American journal of respiratory and critical care medicine.

[23]  S. Jiménez-Morales,et al.  BLK and BANK1 polymorphisms and interactions are associated in Mexican patients with systemic lupus erythematosus , 2019, Inflammation Research.

[24]  T. Matsushita.  Regulatory and effector B cells: Friends or foes? , 2019, Journal of dermatological science.

[25]  G. Lian,et al.  Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline , 2018, Experimental biology and medicine.

[26]  M. Post,et al.  Alveolar capillary dysplasia with misalignment of the pulmonary veins: clinical, histological, and genetic aspects , 2018, Pulmonary circulation.

[27]  H. Fan,et al.  BANK1 alters B cell responses and influences the interactions between B cells and induced T regulatory cells in mice with collagen-induced arthritis , 2018, Arthritis Research & Therapy.

[28]  M. Gillespie,et al.  Fifty Years of Monocrotaline-Induced Pulmonary Hypertension: What Has It Meant to the Field? , 2017, Chest.

[29]  Wei Liu,et al.  [Weighted gene co-expression network analysis in biomedicine research]. , 2017, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

[30]  T. Vyse,et al.  B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis , 2017, Annals of the rheumatic diseases.

[31]  Steven G. Blanchard,et al.  Pathview Web: user friendly pathway visualization and data integration , 2017, Nucleic Acids Res..

[32]  A. Tonevitsky,et al.  Receptor Mincle promotes skin allergies and is capable of recognizing cholesterol sulfate , 2017, Proceedings of the National Academy of Sciences.

[33]  Yan Xu,et al.  FOXF1 maintains endothelial barrier function and prevents edema after lung injury , 2016, Science Signaling.

[34]  K. Toellner,et al.  Regulation of germinal center B‐cell differentiation , 2016, Immunological reviews.

[35]  D. Scadden,et al.  Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-κB inflammatory pathway , 2016, Proceedings of the National Academy of Sciences.

[36]  R. Hendriks,et al.  BTK Signaling in B Cell Differentiation and Autoimmunity. , 2015, Current topics in microbiology and immunology.

[37]  Sam J. Mathew,et al.  The Groucho/Transducin‐like enhancer of split protein family in animal development , 2015, IUBMB life.

[38]  Ping Shen,et al.  Antibody-independent functions of B cells: a focus on cytokines , 2015, Nature Reviews Immunology.

[39]  Yuqi Cai,et al.  FOXF1 Transcription Factor Is Required for Formation of Embryonic Vasculature by Regulating VEGF Signaling in Endothelial Cells , 2014, Circulation research.

[40]  M. Humbert,et al.  Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. , 2014, Circulation research.

[41]  Justin C. Boucher,et al.  B-lymphocyte tolerance and effector function in immunity and autoimmunity , 2013, Immunologic research.

[42]  M. Yeager,et al.  Bronchus-associated lymphoid tissue in pulmonary hypertension produces pathologic autoantibodies. , 2013, American journal of respiratory and critical care medicine.

[43]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[44]  B. Treanor.  B‐cell receptor: from resting state to activate , 2012, Immunology.

[45]  F. Thaiss,et al.  Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. , 2012, Blood.

[46]  H. Drummond,et al.  TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's disease. , 2011, Gastroenterology.

[47]  I. Sjaastad,et al.  Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[48]  Christopher S Coffey,et al.  Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) , 2010, Circulation.

[49]  Facundo D Batista,et al.  Early events in B cell activation. , 2010, Annual review of immunology.

[50]  M. Mayes,et al.  BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians , 2009, Annals of the rheumatic diseases.

[51]  Anne-Kathrin Kienzler,et al.  B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans , 2009, Proceedings of the National Academy of Sciences.

[52]  Tomas W. Fitzgerald,et al.  Genomic and Genic Deletions of the FOX Gene Cluster on 16q24.1 and Inactivating Mutations of FOXF1 Cause Alveolar Capillary Dysplasia and Other Malformations , 2009, American journal of human genetics.

[53]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[54]  S. Hennigan,et al.  Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report , 2008, Lupus.

[55]  L. Bäckdahl,et al.  Cellular distribution of the C-type II lectin dendritic cell immunoreceptor (DCIR) and its expression in the rheumatic joint: identification of a subpopulation of DCIR+ T cells , 2008, Annals of the rheumatic diseases.

[56]  H. Sanjo,et al.  BANK negatively regulates Akt activation and subsequent B cell responses. , 2006, Immunity.

[57]  U. Siebenlist,et al.  Control of lymphocyte development by nuclear factor-κB , 2005, Nature Reviews Immunology.

[58]  J. Kutok,et al.  TNF Family Member B Cell-Activating Factor (BAFF) Receptor-Dependent and -Independent Roles for BAFF in B Cell Physiology1 , 2004, The Journal of Immunology.

[59]  L. Lim,et al.  Transcription factors in mouse lung development and function. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[60]  W. Strober,et al.  The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response , 1996, The Journal of experimental medicine.

[61]  Klaus Rajewsky,et al.  Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice , 1995, Nature.

[62]  B. Koller,et al.  Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. , 1995, Immunity.

[63]  C. Civin,et al.  Flow cytometric analysis of normal B lymphoid development. , 1988, Pathology and immunopathology research.